🇺🇸 FDA

Company profile · Sponsor

Anika

Anika Therapeutics S.r.l.

NIKA · NYSE pharma HENDERSON, NV, EU
Pipeline
0
Drugs
0
Patents
8

Quick answer

Anika (NIKA) is a pharma company. headquartered in HENDERSON, NV, EU. listed on NYSE. NovaPharmaNews links 0 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker NIKA
Exchange NYSE
Company type pharma
Headquarters HENDERSON, NV, EU
SEC CIK 0001145604

Pipeline (0)

No pipeline programs linked yet.

Patents (8)

Search patents →

  1. US 12415779

    Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12391642

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12331026

    Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12264167

    Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12171741

    2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12077506

    Indane derivatives as hypoxia inducible factor-2(α) inhibitors

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11939303

    Sulfamate derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, their medical use and the method of obtaining 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamate derivatives

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11753366

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Anika?

Anika (NIKA) is a pharma company. headquartered in HENDERSON, NV, EU. listed on NYSE. NovaPharmaNews links 0 pipeline programs, 0 drugs, and 8 patents to this profile..

Does Anika have pipeline programs in our database?

No pipeline programs are currently linked to Anika. Programs may be added as ClinicalTrials.gov sponsor matching improves — check back or search the global pipeline directory.

Where does Anika company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.